Zero Childhood Cancer National Symposium

Activity: Other

Description

Eadie LN, Schutz CE, Page EC, Lagonik E, Forgione MO, Rehn JA, Hughes TP, Yeung DT, White DL.
Asciminib is a novel targeted inhibitor of the NUP214::ABL1 fusion gene in childhood acute lymphoblastic leukaemia
Poster Presentation
Sydney, New South Wales
Period26 Oct 202227 Oct 2022
Degree of RecognitionNational